General Information of This Payload
Payload ID
PAY0QUEHW
Name
Tubulysin analogue 3
Synonyms
Tubulysin analogue 3
   Click to Show/Hide
Target(s) Microtubule (MT)
Structure
Formula
C38H57N5O7S
Isosmiles
CCC(C)C(NC(=O)C1CCCCN1C)C(=O)N(C)C(CC(OC(C)=O)c1nc(C(=O)NC(Cc2ccccc2)CC(C)C(=O)O)cs1)C(C)C
InChI
InChI=1S/C38H57N5O7S/c1-9-24(4)33(41-35(46)30-17-13-14-18-42(30)7)37(47)43(8)31(23(2)3)21-32(50-26(6)44)36-40-29(22-51-36)34(45)39-28(19-25(5)38(48)49)20-27-15-11-10-12-16-27/h10-12,15-16,22-25,28,30-33H,9,13-14,17-21H2,1-8H3,(H,39,45)(H,41,46)(H,48,49)
InChIKey
POBZYODNVHQLFG-UHFFFAOYSA-N
Pharmaceutical Properties
Molecule Weight
727.969
Polar area
158.24
Complexity
51
xlogp Value
5.0875
Heavy Count
51
Rot Bonds
18
Hbond acc
9
Hbond Donor
3
The activity data of This Payload
Standard Type Value Units Cell line Disease Model Cell line ID Reference
Half-maximal effective concentration (EC50) 0.72 nmol/L
L-540 cells
Hodgkin lymphoma
CVCL_1362 
[1]
Half-maximal effective concentration (EC50) 0.9 nmol/L
L-428 cells
Hodgkin lymphoma
CVCL_1361 
[1]
Half-maximal effective concentration (EC50) 4 nmol/L
786-O cells
Renal cell carcinoma
CVCL_1051 
[1]
Each Antibody-drug Conjugate Related to This Payload
References
Ref 1 Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates. Mol Cancer Ther. 2016 May;15(5):938-45.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.